<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02345317</url>
  </required_header>
  <id_info>
    <org_study_id>AltenAugenklinik</org_study_id>
    <nct_id>NCT02345317</nct_id>
  </id_info>
  <brief_title>Reticular Pseudodrusen Progression Study</brief_title>
  <official_title>Reticular Pseudodrusen Progression Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Muenster</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Muenster</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in
      industrial countries. Reticular pseudodrusen (RPD) have been recognized as an additional
      phenotypic characteristic frequently observed in patients with AMD. Several studies have
      proven that the prevalence of RPD is associated with AMD as well as a high risk of disease
      progression to geographic atrophy, the late form of dry AMD. The pathogenesis of RPD is yet
      still incompletely understood. Retrospective studies have demonstrated that the RPD affected
      retinal area increases over time. Potential factors influencing progression of RPD have not
      been intensely studied and potentially predictive markers are yet unknown. The primary
      objective of this study is to characterize RPD progression in more detail and to identify
      predictive markers of RPD progression and development of AMD late stages.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2014</start_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change of reticular pseudodrusen affected retinal area to baseline</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Age-related Macular Degeneration</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients suitable for the study will be recruited at the University of Muenster, Department
        of Ophthalmology
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent

          -  Men and women, any race, aged 60 years or older at the baseline visit

          -  Presence of RPD without any other type of drusen, hypo/hyperpigmentation, geographic
             atrophy, choroidal neovascularization

          -  Patient is willing to undergo ocular examinations once every 12 for up to 24 months

        Exclusion Criteria:

          -  Presence or history of soft drusen, hypo-/hyperpigmentation, geographic atrophy or
             choroidal neovascularization in the study eye

          -  Ocular disease in the study eye that may confound assessment of the retina (e.g.,
             diabetic retinopathy, uveitis)

          -  Any condition that would make adherence to the examination schedule of once every 12
             months for up to 24 months difficult or unlikely, e.g., personality disorder, chronic
             alcoholism, Alzheimer's Disease or drug abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicole Eter, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Ophthalmology, University Medical Center Muenster</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Florian Alten, MD</last_name>
    <phone>+492518356001</phone>
    <email>florian.alten@ukmuenster.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Silvia Falkenau</last_name>
    <phone>+492518356048</phone>
    <email>silvia.falkenau@ukmuenster.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Ophthalmology, University Medical Center Muenster</name>
      <address>
        <city>Muenster</city>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florian Alten, MD</last_name>
      <phone>+492518356001</phone>
      <email>florian.alten@ukmuenster.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Alten F, Heiduschka P, Clemens CR, Eter N. Longitudinal structure/function analysis in reticular pseudodrusen. Invest Ophthalmol Vis Sci. 2014 Aug 21;55(9):6073-81. doi: 10.1167/iovs.13-13804.</citation>
    <PMID>25146989</PMID>
  </reference>
  <reference>
    <citation>Alten F, Clemens CR, Heiduschka P, Eter N. Characterisation of reticular pseudodrusen and their central target aspect in multi-spectral, confocal scanning laser ophthalmoscopy. Graefes Arch Clin Exp Ophthalmol. 2014 May;252(5):715-21. doi: 10.1007/s00417-013-2525-y. Epub 2013 Nov 26.</citation>
    <PMID>24276561</PMID>
  </reference>
  <reference>
    <citation>Alten F, Clemens CR, Heiduschka P, Eter N. Localized reticular pseudodrusen and their topographic relation to choroidal watershed zones and changes in choroidal volumes. Invest Ophthalmol Vis Sci. 2013 May 7;54(5):3250-7. doi: 10.1167/iovs.13-11923.</citation>
    <PMID>23599330</PMID>
  </reference>
  <reference>
    <citation>Alten F, Heiduschka P, Clemens CR, Eter N. Multifocal electroretinography in eyes with reticular pseudodrusen. Invest Ophthalmol Vis Sci. 2012 Sep 14;53(10):6263-70. doi: 10.1167/iovs.12-10094.</citation>
    <PMID>22918638</PMID>
  </reference>
  <reference>
    <citation>Alten F, Clemens CR, Milojcic C, Eter N. Subretinal drusenoid deposits associated with pigment epithelium detachment in age-related macular degeneration. Retina. 2012 Oct;32(9):1727-32.</citation>
    <PMID>22466490</PMID>
  </reference>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 19, 2015</study_first_submitted>
  <study_first_submitted_qc>January 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2015</study_first_posted>
  <last_update_submitted>January 19, 2015</last_update_submitted>
  <last_update_submitted_qc>January 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

